DocsDock200's profile picture. ASH President 2023 @ASH_Hematology. Chief of Hematology Johns Hopkins.

Robert Brodsky

@DocsDock200

ASH President 2023 @ASH_Hematology. Chief of Hematology Johns Hopkins.

Nothing like puppy love.

DocsDock200's tweet image. Nothing like puppy love.
DocsDock200's tweet image. Nothing like puppy love.

Patient give to best perspective of sickle cell disease. Everyone is different but many common themes. podcasts.apple.com/us/podcast/blo…


Congrats to Valerie Bey @heartsickle1 and the Northern Va sickle cell disease association on their podcast Blood, Sweat, and Cells. Greatful to be part of but esp inspired by the patient stories Valerie brings to life. podcasts.apple.com/us/podcast/blo…


Five former ASH presidents in NYC @NYASciences for great symposium on sickle cell disease. One of them 🙁 still doesn't know how to wear a name tag.@ASH_hematology

DocsDock200's tweet image. Five former ASH presidents in NYC @NYASciences for great symposium on sickle cell disease. One of them 🙁 still doesn't know how to wear a name tag.@ASH_hematology

Genetic and Epigenetic Dysregulation of CR1 is Associated with Catastrophic Antiphospholipid Syndrome (CAPS) | medRxiv New insight as to what makes (CAPS) catastrophic! Now we may be able to stop it from being catastrophic. nam02.safelinks.protection.outlook.com/?url=https%3A%…


The procedure would greatly expand the pool of potential donors, in addition to costing less than one-quarter of the price of innovative gene therapies. Source: Axios search.app/qV26Ke9E6k7qVZ…


Robert Brodsky reposted

Almost every patient can have a haplo donor available, now we can say this approach is safe and effective for sickle cell disease. While gene therapies are effective too, access and cost (here and globally) will be major issues #bmtsm

Out in NEJM Evidence today. KEY TAKEAWAYS •Of 42 people with severe SCD who had the procedure , 95% were alive at 2 yrs, and 88% are considered cured. •Most people with SCD are eligible, which costs a fraction of the price of gene editing/therapy #casgevy @ASH_hematology

DocsDock200's tweet image. Out in NEJM Evidence today. KEY TAKEAWAYS 
•Of 42 people with severe SCD who had the procedure , 95% were alive at 2 yrs, and 88% are considered cured.
•Most people with SCD are eligible, which costs a fraction of the price of gene editing/therapy
#casgevy @ASH_hematology


Robert Brodsky reposted

🚨🎧NEW EPISODE! In this episode, our MD, Dr. Brad Lewis, talks with Dr. Robert Brodsky about a new test he and his lab have recently developed: modified HAM (mHam). Listen here ➡️ bit.ly/3D3kBQ6

MachaonDx's tweet image. 🚨🎧NEW EPISODE! In this episode, our MD, Dr. Brad Lewis, talks with Dr. Robert Brodsky about a new test he and his lab have recently developed: modified HAM (mHam). Listen here ➡️ bit.ly/3D3kBQ6

Introducing mHam 2.0 Podcast on this site is a nice primer for housestaff, fellows and others on complement-based diagnostics and TMAs. mham.machaondiagnostics.com


Most powerful diagnostic and monitoring assay for aHUS/CM-TMA now available. #ASH24 Can also monitor any complement inhibitors used for PNH, M. Gravis, CAD etc.

DocsDock200's tweet image. Most powerful diagnostic and monitoring assay for aHUS/CM-TMA now available. #ASH24 Can also monitor any complement inhibitors used for PNH, M. Gravis, CAD etc.

Loading...

Something went wrong.


Something went wrong.